Adverse selection and consumer inertia: empirical evidence from the Dutch health insurance market Ramsis R. CroesFrederik T. SchutMarco Varkevisser Original Paper Open access 01 October 2024
Assessing a decade of leukaemia-related premature mortality costs: impact on productivity loss in Spain Josep DarbàMeritxell AscanioAinoa Agüera Original Paper Open access 28 September 2024
The societal cost of ‘unwanted’ loneliness in Spain Bruno CasalEva Rodríguez-MiguezBerta Rivera Original Paper Open access 28 September 2024
Comparison of the EQ-5D-Y and the CHU-9D instruments in a general child population based on self-reports and proxy-reports Yan LiYanqiu ChenPingyu Chen Original Paper 28 September 2024
Comparison of four approaches in eliciting health state utilities with SF-6Dv2 Hosein AmeriThomas G. Poder Original Paper 28 September 2024
Comparing EQ-5D-5L, PROPr, SF-6D and TTO utilities in patients with chronic skin diseases Ákos SzabóValentin BrodszkyFanni Rencz Original Paper Open access 28 September 2024
Strategic behavior and entry deterrence by branded drug firms: the case of authorized generic drugs Lu YaoMengde Liu Original Paper 24 September 2024
Does implementing opt-out solve the organ shortage problem? Evidence from a synthetic control approach Selina Schulze Spuentrup Original Paper 20 September 2024
An assessment of the implications of distribution remuneration and taxation policies on the final prices of prescription medicines: evidence from 35 countries Giovanny LeonChristophe CarbonelPanos Kanavos Original Paper Open access 19 September 2024
Should Scotland provide genome-wide sequencing for the diagnosis of rare developmental disorders? A cost-effectiveness analysis Michael AbbottMandy RyanZosia Miedzybrodzka Original Paper Open access 09 September 2024
Valuation of the EQ-5D-3L in Jordan Abeer Al RabayahBram RoudijkUwe Siebert Original Paper Open access 03 September 2024
Trends in NICE technology appraisals of non-small cell lung cancer drugs over the last decade Lotte WesterinkSharon WoltersMaarten Jacobus Postma Original Paper Open access 30 August 2024
The added value of the cognition, dining, gastrointestinal problems, sleep and tiredness bolt-on dimensions to the EQ-5D-5L in patients with coeliac disease M. Mercédesz AngyalMathieu F. JanssenFanni Rencz Original Paper Open access 30 August 2024
Cost effectiveness of a GP delivered medication review to reduce polypharmacy and potentially inappropriate prescribing in older patients with multimorbidity in Irish primary care: the SPPiRE cluster randomised controlled trial Paddy GillespieFrank Moriartyfor the SPPiRE Study team Original Paper Open access 27 August 2024
Cost-effectiveness of hydroxychloroquine retinopathy screening: the current guideline versus no screening and reduced regimens Sara W. QuistSophie te DorsthorstFreekje van Asten Original Paper Open access 20 August 2024
Time value of informal care of people with alzheimer’s disease in Spain: a population-based analysis Vilaplana-Prieto COliva-Moreno J Original Paper Open access 09 August 2024
A critical review of the use of R2 in risk equalization research Wynand P. M. M. van de VenRichard C. van Kleef Original Paper Open access 09 August 2024
Testing four cognition bolt-on items to the EQ-5D in a general Chinese population Meixia LiaoHongyan WuNan Luo Original Paper 09 August 2024
The formal care costs of dementia: a longitudinal study using Swedish register data Jennifer ZillingUlf-G. GerdthamSofie Persson Original Paper Open access 30 July 2024
Psychometric validation of the Chinese versions of EQ-5D-Y-3L and the experimental EQ-TIPS in children and adolescents with COVID-19 Wenjing ZhouYaqin LiYanming Lu Original Paper Open access 27 July 2024
Economies of scope in the Norwegian public hospital sector Nils Arne LindaasKjartan Sarheim AnthunJon Magnussen Original Paper Open access 18 July 2024
Migration-related determinants of health-care service utilization among persons with a direct migration background in Germany: an exploratory study based on the German Socio-Economic Panel (SOEP) Thomas GrochtdreisHans-Helmut KönigJudith Dams Original Paper Open access 15 July 2024
Incentivizing adherence to pre-exposure prophylaxis for HIV prevention: a randomized pilot trial among male sex workers in Mexico Omar GalárragaMarta Wilson-BarthesDon Operario Original Paper 13 July 2024
The EQ-5D-3L valuation study for Bermuda: using an on-line EQ-VT protocol Henry BaileyBram RoudijkRicky Brathwaite Original Paper Open access 09 July 2024
A budget impact analysis of a digital monitoring solution in patients treated with oral anticancer agents: a medico-economic analysis of the randomized phase 3 CAPRI trial Etienne MinvielleHenri LeleuFlorian Scotté Original Paper 28 June 2024
The hidden cost of sophistication: economic complexity and obesity Ronald DjeunankanSosson TadadjeuUmmad Mazhar Original Paper 11 June 2024
Does medial tourism promote growth in healthcare sector? Hassan F. GholipourKourosh Esfandiar Original Paper Open access 06 June 2024
Population normative data for OxCAP-MH capability scores Péter György BalázsAgata ŁaszewskaValentin Brodszky Original Paper Open access 24 May 2024
Workload and short sickness absences in a cohort of Finnish hospital employees Tero KuusiMartti KulvikAnnina Ropponen OriginalPaper 23 May 2024
Monetary value of health—a practical decision-making framework combining equity considerations and WTP Elizabeta RibarićIsmar VelićAna Bobinac Original Paper 20 May 2024
Cost-effectiveness analysis of procalcitonin and lung ultrasonography guided antibiotic prescriptions in primary care Giulio CiscoArmando N. MeierJoachim Marti Original Paper Open access 18 May 2024
Long-term returns to local health-care spending Jakub ČervenýJan C. van Ours Original Paper Open access 18 May 2024
Costs associated with insufficient physical activity in Germany: cross-sectional results from the baseline examination of the German national cohort (NAKO) Sophie GottschalkHans-Helmut KönigJudith Dams Original Paper Open access 10 May 2024
Do institutions matter for citizens’ health status? Empirical evidence from Italy M. Alessandra AntonelliGiorgia Marini Original Paper Open access 09 May 2024
Is there a link between health care utilisation and subjective well-being? An exploratory study among older Danes Maiken Skovrider AaskovenTrine KjærDorte Gyrd-Hansen Original Paper Open access 08 May 2024
The impact of different perspectives on the cost-effectiveness of remote patient monitoring for patients with heart failure in different European countries Hamraz MokriPieter van BaalMaureen Rutten-van Mölken Original Paper Open access 03 May 2024
Mapping functions for the PHQ-9 and GAD-7 to generate EQ-5D-3L for economic evaluation Clara MukuriaMatthew FranklinSebastian Hinde Original Paper Open access 25 April 2024
Economic assessment of abemaciclib for the adjuvant treatment of luminal HER2- breast cancer from the perspective of the Spanish health system Silvia Fenix-CaballeroAdrián Sanchez-VegasAntonio Olry de Labry Lima Original Paper 22 April 2024
Healthcare resource utilisation and direct medical cost for individuals with 5q spinal muscular atrophy in Sweden Thomas SejersenSophie GrahamAlex Simpson Original Paper Open access 20 April 2024
Economic evaluation of intensive home treatment in comparison to care as usual alongside a randomised controlled trial Ansam BarakatJurgen E. CornelisMatthijs Blankers Original Paper Open access 10 April 2024
The performance of the EQ-HWB-S as a measure of quality-of-life of caregivers in families that have experienced adverse events Cate BaileyKim DalzielTessa Peasgood Original Paper Open access 05 April 2024
Comparing GPs according to their model of practice: are multiprofessional group practices associated with more favourable working conditions? Myriam BiaisMatthieu CassouCarine Franc Original Paper 03 April 2024
Poverty, work intensity, and disability: evidence from European countries Chiara MussidaDario Sciulli Original Paper Open access 26 March 2024
Costs attributable to hypercholesterolemia in a single period and over the life cycle Stephanie ReitzingerMiriam ReissThomas Czypionka Original Paper Open access 22 March 2024
From test to rest: evaluating socioeconomic differences along the COVID-19 care pathway in the Netherlands Iris MeulmanEllen UitersNiek Stadhouders Original Paper Open access 18 March 2024
The EORTC QLU-C10D is a valid cancer-specific preference-based measure for cost-utility and health technology assessment in the Netherlands Micha J. PilzSimon SeyringerEva Maria Gamper Original Paper Open access 14 March 2024
Economic value of diastasis repair with the use of mesh compared to no intervention in Italy Carla RognoniAlessandro CarraraRosanna Tarricone Original Paper Open access 14 March 2024
Antivirals to prepare for surges in influenza cases: an economic evaluation of baloxavir marboxil for the Netherlands Simon van der PolMaarten J. PostmaCornelis Boersma Original Paper Open access 14 March 2024
The causal effect of early retirement on medication use across sex and occupation: evidence from Danish administrative data Jolien CremersTorben Heien NielsenClaus Thorn Ekstrøm Original Paper 13 March 2024
